AstroNova (ALOT) Financials

AstroNova’s latest quarter shows a meaningful earnings recovery. In Q1 fiscal 2027, revenue rose to $39.4 million from $33.0 million in the restated year-ago quarter, a 19% increase. Gross profit increased 21% to $14.4 million, while gross margin improved modestly to approximately 36.6% from 36.3%. Operating income nearly tripled to $1.6 million, and the company returned to profitability with net income of $653,000, or $0.09 per basic share, compared with a $376,000 loss and a $0.05 loss per share in Q1 fiscal 2026.

The balance sheet and cash flow show both progress and areas to monitor. AstroNova generated $3.0 million of operating cash flow in Q1 fiscal 2027, although that was below $4.4 million in the year-ago quarter. Cash increased to $4.7 million during the quarter, while total debt declined to approximately $35.9 million from $44.7 million a year earlier. However, cash remains modest relative to short-term debt of $19.7 million, and interest expense continues to consume a significant portion of operating profit. The company’s current ratio was approximately 1.8 at quarter-end, supported by a reduction in inventory from $51.5 million a year ago to $43.9 million.

• Revenue momentum improved: Q1 fiscal 2027 revenue increased approximately 19% year over year to $39.4 million, recovering toward the company’s stronger quarterly levels.
• Profitability rebounded: Operating income rose to $1.6 million from $571,000 a year earlier, and net income improved from a $376,000 loss to a $653,000 profit.
• Gross margins remained healthy: Gross margin was approximately 36.6%, above the 32.2% recorded in Q2 fiscal 2026 and close to the 36.2% reported in Q3 fiscal 2026.
• Debt reduction continued: Total short- and long-term debt fell by roughly $8.8 million year over year to $35.9 million, reducing balance-sheet leverage.
• Operating cash flow stayed positive: AstroNova generated $3.0 million from operations in the latest quarter and used part of that cash to repay debt.
• Inventory management improved: Net inventory declined approximately 15% year over year to $43.9 million, which could reduce working-capital pressure if sales continue to grow.
• Liquidity is adequate but not abundant: Current assets of $74.7 million exceeded current liabilities of $42.4 million, producing a current ratio near 1.8, but cash and equivalents were only $4.7 million.
• Comparability requires caution: Some historical fiscal 2025 and fiscal 2026 figures were marked as restated or calculated, so investors should rely on the latest reported versions when evaluating longer-term trends.
• Operating expenses grew faster than revenue in some areas: Total operating expenses increased to $12.9 million from $11.4 million year over year, with selling, general and administrative expense up approximately 26% and research and development expense up approximately 18%.
• Interest expense remains a material burden: Q1 interest expense was $675,000, equal to roughly 43% of operating income, limiting the conversion of operating gains into bottom-line earnings.